4554 — Fuji Pharma Co Cashflow Statement
0.000.00%
Last trade - 00:00- ¥33bn
- ¥60bn
- ¥46bn
- 55
- 83
- 89
- 90
Annual cashflow statement for Fuji Pharma Co, fiscal year end - September 30th, JPY millions except per share, conversion factor applied.
2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | 2024 September 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 2,918 | 3,371 | 3,723 | 4,399 | 8,276 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | -216 | 497 | -175 | -556 | -3,997 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 1,010 | 19 | -6,952 | -4,947 | -3,808 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 5,769 | 5,993 | -659 | 1,919 | 4,151 |
| Capital Expenditures | -2,615 | -3,896 | -12,423 | -3,897 | -4,372 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -1 | 1,551 | 1,152 | -1,343 | 2,714 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -2,616 | -2,345 | -11,271 | -5,240 | -1,658 |
| Financing Cash Flow Items | -1 | -2 | -1 | -1 | 11 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 450 | -5,435 | 5,094 | 1,915 | -435 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 3,547 | -1,842 | -6,653 | -1,221 | 2,260 |